Milestone Pharmaceuticals (MIST) Receives a Buy from TD Cowen
In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), with ...
FiercePharma8h
ICER raises cost-effective price for Pfizer's ATTR drug in final analysis but still calls for hefty discount
After calling for a major discount for Pfizer’s popular transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis, a U.S.
Zacks.com on MSN9h
Gilead, MRK Report Data From Investigational Combination Study for HIV
Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
Alnylam price target raised to $371 from $282 at TD Cowen
TD Cowen raised the firm’s price target on Alnylam (ALNY) to $371 from $282 and keeps a Buy rating on the shares. The firm updated its ...
NVO's Alhemo Gets Positive CHMP Opinion in EU for Haemophilia A or B
The CHMP of the regulatory body in the EU adopts a positive opinion recommending the approval of Novo Nordisk's Alhemo for ...